FATE THERAPEUTICS INC — Director's Dealing 2014

Jun 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2014-06-09

Reporting Person: Flynn Peter D (See remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-09	Common Stock	M	1260	$1.63	Acquired	6645	Direct
2014-06-09	Common Stock	S	1955	$7	Disposed	4690	Direct
2014-06-10	Common Stock	M	699	$1.63	Acquired	5389	Direct
2014-06-10	Common Stock	S	1350	$7	Disposed	4039	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-09	Stock Option (right to buy)	$1.63	M	1260	Disposed	2022-02-08	Common Stock (1260)	Direct
2014-06-10	Stock Option (right to buy)	$1.63	M	699	Disposed	2022-02-08	Common Stock (699)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2013.

F2: The shares subject to this option shall vest and become exercisable at the rate of 1/4th of the shares on May 30, 2012 and 1/48th of the shares each month thereafter such that this option is fully exercisable on May 30, 2015. This option is subject to accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.

F3: Not applicable.